Navigation Links
Elegant delivery
Date:7/15/2012

Cancers are notorious for secreting chemicals that confuse the immune system and thwarting biological defenses.

To counter that effect, some cancer treatments try to neutralize the cancer's chemical arsenal and boost a patient's immune response--though attempts to do both at the same time are rarely successful.

Now, researchers have developed a novel system to simultaneously deliver a sustained dose of both an immune-system booster and a chemical to counter the cancer's secretions, resulting in a powerful therapy that, in mice, delayed tumor growth, sent tumors into remission and dramatically increased survival rates.

The researchers, all from Yale University, report their findings in the July 15, 2012, issue of Nature Materials.

The new immunotherapy incorporates well-studied drugs, but delivers them using nanolipogels (NLGs), a new drug transport technology the researchers designed. The NLGs are nanoscale, hollow, biodegradable spheres, each one capable of accommodating large quantities of chemically diverse molecules.

The spheres appear to accumulate in the leaky vasculature, or blood vessels, of tumors, releasing their cargo in a controlled, sustained fashion as the spherule walls and scaffolding break down in the bloodstream.

For the recent experiments, the NLGs contained two components: an inhibitor drug that counters a particularly potent cancer defense called transforming growth factor-β (TGF-β), and interleukin-2 (IL-2), a protein that rallies immune systems to respond to localized threats.

"You can think of the tumor and its microenvironment as a castle and a moat," says Tarek Fahmy, the Yale University engineering professor and NSF CAREER grantee who led the research. "The 'castles' are cancerous tumors, which have evolved a highly intelligent structure--the tumor cells and vasculature. The 'moat' is the cancer's defense system, which includes TGF-β.
'/>"/>

Contact: Josh Chamot
jchamot@nsf.gov
703-292-7730
National Science Foundation
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial
3. Light-induced delivery of nitric oxide eradicates drug-resistant bacteria
4. Oligonucleotide Delivery: Biology, Engineering and Development Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Elegant delivery
(Date:4/2/2015)... 2015 Fingerprint Cards (FPC) has ... from the distributor World Peace Industrial Group (WPI), part ... although the major part of the shipments will take ... by smartphone manufacturers in China . ... the communicated revenue guidance of + 1 000 MSEK for ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications Corp. ... global provider of Software Defined Network Architecture (ET Software ... total revenue of approximately $20.4 million for the year ... $19.5 million for the year ended December 31, 2013. ... the Company had completed its multi-year transition away from ...
(Date:3/26/2015)... 2015 The Granite Club, ... athletic club, today announced it has implemented a state-of-the-art ... movement for members and staff, while restricting access to ... we selected FST,s IMID Access system because it has ... members and staff, in addition to unparalleled security," said ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... for related viruses including dengue fever. A monoclonal antibody ... virus has an intriguing secret: Contrary to scientists' expectations, ... to host cells. Instead, the antibody somehow stops the ... was a complete surprise to us, but it gives ...
... cottonseed could help improve the effectiveness of chemotherapy at ... of Michigan Comprehensive Cancer Center have found. , The ... journal Molecular Cancer Therapeutics, could lead to a treatment ... cancer, helping patients preserve vital organs involved in speech ...
... Regenerative medicine scientists at the University of Florida's McKnight ... that for the first time duplicates neurogenesis -- the ... dish. , Writing in today's (June 13) Proceedings of ... culture method that holds the promise of producing a ...
Cached Biology News:Secrets to antibody's success against West Nile Virus surprise scientists 2Secrets to antibody's success against West Nile Virus surprise scientists 3Secrets to antibody's success against West Nile Virus surprise scientists 4Compound from Chinese medicine shows promise in head and neck cancer 2Compound from Chinese medicine shows promise in head and neck cancer 3For first time, brain cells generated in a dish 2For first time, brain cells generated in a dish 3
(Date:5/6/2015)... 2015 Follow us on ... nanomaterial with diameter ranging between 2 to 10 ... nanophotonics materials market. The unique electroluminescent, photoluminescent, photo-physical, ... quantum confinement effect render the nanoparticles versatile and ... scientific, technological, and commercial applications. A host of ...
(Date:5/6/2015)... 2015   University of Maryland (UM) Ventures ... signing of an exclusive option by Biomecite Diagnostics for ... develop diagnostics to detect inflammatory bowel diseases (IBD), such ... Florian Fricke and James White ... University of Maryland School of Medicine,s Institute for Genome ...
(Date:5/6/2015)... TAMPA, Fla. , May 6, 2015  Oxis ... International, Inc. OTC: OXIS, OXI.PA, announced today that ... Oncology, Division of Cancer Medicine at the University of ... board.  Dr. Yee is also Professor, Department of Immunology, ... Therapy, Center for Cancer Immunology Research at the University ...
(Date:5/6/2015)... Whitefox ( http://www.whitefox.com ... has signed an agreement with  California ... the delivery of an industrial scale membrane system. The ... water, energy and emissions in the production ... project is fully aligned with ...
Breaking Biology Technology:Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3Whitefox Signs Agreement With Pacific Ethanol Inc. 2
... 21 Chimerix, Inc., a biotechnology company developing orally-available antiviral ... with the appointment of Timothy King , MSPH, as Vice ... of Clinical Research.   , ... In these new roles, Mr. King will oversee clinical ...
... United Therapeutics Corporation (Nasdaq: UTHR ) announced today that it will ... Wednesday, July 28, 2010 . , ... United Therapeutics will host a half-hour teleconference on Wednesday, July ... is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
... July 20, 2010The Life Sciences Discovery Fund (LSDF) ... state-based research teams to support commercial development of ... improving the success rate of lumbar punctures (spinal ... effective magnetic resonance imaging (MRI) contrast agent; enhancing ...
Cached Biology Technology:Chimerix Appoints Two New Vice Presidents to Clinical Management Team 2Chimerix Appoints Two New Vice Presidents to Clinical Management Team 3Life Sciences Discovery Fund announces commercialization grants 2
... The InnoCyte Laminin-Based 96-well Cell Invasion ... capacity of cells using laminin as a ... potential anti-metastatic agents in vitro in a ... pore size is appropriate for all types ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ID ...
... tumor, Polyclonal Antibody, Unconjugated ... at a dilution of 1/100. IP: ... WB: Use at an assay dependent ... Not tested in other applications. ...
... The Arabidopsis 2 Oligo Microarray Kit (V2), ... growth stages, and stress response. Each microarray contains ... of The Institute for Genomic Research (TIGR) and ... contains 5 standard 1 x 3? glass ...
Biology Products: